Blood technologies company Entegrion has been awarded a $43.7 million defense contract to develop one of its investigational blood products into a substitute for fresh frozen plasma. The Department of Defense will fund development of Resusix, Entegrion’s dehydrated human plasma. Resusix will become Entegrion’s first investigational new drug application filing. Research Triangle Park, North Carolina-based […]
Ireland-based plastics company Mergon is no stranger to the United States. Since 1998, its South Carolina manufacturing plant has made plastics for automotive and industrial manufacturers and suppliers. Healthcare plastics comprise a smaller part of Mergon’s business. When the global economy tumbled in 2008, Mergon saw its industrial and automotive orders slow down. But healthcare […]
At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch.